The diagnosis and management of chronic heart failure in the older patient

British Medical Bulletin

Volumn 75-76, Issue 1, 2005, Pages 49-62

  Gillespie, Neil D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Diagnosis; Heart failure; Treatment

Indexed keywords

ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; BUCINDOLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; LISINOPRIL; METOLAZONE; METOPROLOL; METOPROLOL TARTRATE; NEBIVOLOL; NITRATE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE;

BLOOD EXAMINATION; CLINICAL FEATURE; DOSE RESPONSE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FATIGUE; HEART EDEMA; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HUMAN; NEPHROTOXICITY; ORTHOSTATIC HYPOTENSION; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENESCENCE; SYMPTOM; SYSTOLE; THORAX RADIOGRAPHY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DIURETICS; ELECTROCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICAL EXAMINATION; REFERRAL AND CONSULTATION;

EID: 33750927359     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldh060     Document Type: Review

References (55)

1. Alexander K, Biswas M. Heart failure and the elderly: Disease diversity, data, and delivery of care. Am Heart J 2003;146:194-6.
2. Ansari M, Massie B. Heart Failure: How big is the problem? Who are the patients? What does the future hold? Am Heart J 2003;146:1-4.
3. Rudinger A, Harjola VP, Muller A et al. Acute heart failure: clinical presentation, one year mortality and prognostic factors. Eur J Heart Fail 2005;7(4):662-70.
4. Morgan S, Smith H, Simpson I et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in a general practice setting: cross-sectional survey. BMJ 1999;318:368-72.
5. Vasan RS. Diastolic heart failure. BMJ 2003;327:1181-2.
6. Kerzner R, Gage B, Freedland K et al. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J 2003;146:286-90.
7. Guidelines for the diagnosis and treatment of chronic heart failure. Task force of the European Society of Cardiology. Eur Heart J 2001;22:1527-60.
8. Ahmed A. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice. J Am Geriatr Soc 2003;51:123-6.
9. Drazner MH, Rame J, Eduardo Dries DL. Third Heart Sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. Am J Med 2003;114:431-7.
10. Davie AP, Francis CM, Caruana L et al. Assessing diagnosis in heart failure: which features are any use? QJM 1997;90(5):335-9.
11. Remes J, Miettinen H, Rennanen A et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12(3):315-21.
12. Remes J, Lansimies E, Pyorala K. Usefulness of M-mode echocardiography in the diagnosis of heart failure. Cardiology 1991;78(3):267-77.
13. Berkin KE. Does everyone in heart failure need echocardiography? Age Ageing 1999;28:421-2.
14. Hurst JW. Observational data suggesting there are electrocardiographic abnormalities that strongly suggest the presence of chronic heart failure. Clin Cardiol 2005;28:154-7.
15. Brozena S, Jessup M. The new staging system for heart failure. Geriatrics 2003;58(6):31-6.
16. Aronow WS, Ahn C, Kronzon I. Prevalence of echocardiographic findings in 554 men and 1243 women aged >60 years in a long term health care facility. Am J Cardiol 1997;79(3):379-80.
17. Fonseca C, Mota T, Morais H et al. EPICA investigators. The value of the electrocardiogram and chest x-ray for confirming or refuting a suspected diagnosis of heart failure in the community. Eur J Heart Fail 2004;6(6):793-4.
18. Zaphiriou A, Robb S, Murray Thomas T et al. The diagnostic accuracy of plasma BNP and NTpro-BNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 2005;7(4):537-41.
19. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001;19:557-71.
20. Tamura K, Takahashi N, Nakatani Y et al. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure. Gerontology 2001;47(1):46-51.
21. Hillis GS, Bloomfield P. Basic transthoracic echocardiography. BMJ 2005;330:1432-6.
22. Torp-Pederson C, Kober L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left ventricular function after acute myocardial infarction. TRACE Study Group. Lancet 1999;354:9-12.
23. Cox NLT, Sainsbury P, McLenachan J et al. Investigating heart failure in elderly people: does everyone need an echocardiogram? Age Ageing 1998;27:291-5.
24. Alexander JH, Peterson ED, Chen AY et al. Feasibility of point of care echocardiography by internal medicine house staff. Am Heart J 2004;147:476-81.
25. Kornowski R, Zeeli D, Averbunch M et al. Intensive home care surveillance prevents hospitalisation and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:162-6.
26. Rich MW, Beckham V, Wittenberg C et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
27. Ekman I, Andersson B, Ehnfors M et al. Feasibility of a nurse monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J 1998;19:1254-60.
28. Sing A, Blackwell J, Neher J. Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction. J Fam Pract 2005;54:370-2.
29. The Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
30. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
31. MERIT-HF investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/LX Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;341:709-17.
32. The Cardiac Insufficiency Bisoprolol Study II Investigators. The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomized trial. Lancet 1999;353:9-13.
33. Packer M, Coats AJ, Fowler MB. Carvedilol Prospective Randomised Cumulative Survival Study Group. Effect of Carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
34. Sin DD, McAlister FA. The effects of B blockers on morbidity and mortality in a population based cohort of 11,942 elderly patients with heart failure. Am J Med 2002;113:650-6.
35. Stewart S, McMurray JJ, Hebborn A et al. THE Copernicus Study Group. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom. Int J Cardiol 2005;100:143-9.
36. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. The Beta-blocker Evaluation of Survival Trial Investigators. N Engl J Med 2001;344:1659-67.
37. Poole-Wilson PA, Swedberg K, Cleland JG. Carvedilol or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial. Lancet 2003;362:7-13.
38. Flather M, Shibata M, Coats A et al. Randomised trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure. (SENIORS). Eur Heart J 2005;26:215-25.
39. Granger CB, McMurray JJV, Yusuf S et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet 2003;362:772-6.
40. Dickstein K. ELITE II and Val-HeFT are different trials: together what do they tell us? Cur Control Trials Cardiovasc Med 2001;2(5):240-3.
41. Yusuf S, Pfeffer MA, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM preserved Trial. Lancet 2003;362:777-81.
42. McMurray JJ, Ostergren J, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. Lancet 2003;362:767-71.
43. The RALES investigators: Effectiveness of spironolactone added to an ACE inhibitor and a loop diuretic for severe congestive heart failure. Am J Cardiol 1996;78:902-7.
44. The Digitalis Investigation group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
45. Alexander KP, Biswas MS. Heart Failure and the elderly: disease diversity, data and delivery of care. Am Heart J 2003;146(2):250-7.
46. Blue L, Lang E, McMurray JJ et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001;323:715-18.
47. Rutten FH, Grobbee DE, Hoes A. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003;5:337-44.
48. Jong P, Gong Y, Liu PP et al. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation 2003;108:184-91.
49. Scottish Intercollegiate Guidelines Network. Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction. SIGN 1999:35.
50. NICE guideline CG5 Chronic Heart Failure: Management of chronic heart failure in adults in primary and secondary care July 2003.
51. Sparrow N, Adlam D, Cowley A et al. Difficulties of introducing the National Service Framework for heart failure into general practice in the UK. Eur J Heart Fail 2003;5:355-61.
52. Houghton AR, Cowley AJ. Managing heart failure in a specialist clinic. Journal of the Royal College of Physicians of London 1997;31:276-9.
53. Hauptman PJ, Havranek EP. Integrating palliative care into heart failure care. Arch Intern Med 2005;165:374-8.
54. DiBianco R. Update on therapy for heart failure. Am J Med 2003;115:480-8.
55. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003;362:147-58.